Industry News

Medical Device Industry News

What Causes Alzheimer’s?

January 14th, 2025|Medical Device News Magazine|

The quest to understand Alzheimer’s disease continues to be a pressing concern, as millions of individuals and their families are affected by this incurable condition. Characterized by memory loss, impaired thinking, and behavioral issues, Alzheimer’s

R3 Vascular Secures WCG IRB Approval and CMS Category B Medicare Coverage for the ELITE-BTK Pivotal Trial of its MAGNITUDEÒ Drug Eluting Next Generation Bioresorbable Scaffold for Below-the-Knee Peripheral Arterial Disease

January 13th, 2025|Medical Device News Magazine|

R3 Vascular Inc., a medical device company dedicated to developing and providing novel, best-in-class bioresorbable scaffolds for treating peripheral arterial disease (PAD), is pleased to announce that it received WCG Institutional Review Board (IRB) approval

Vergent Bioscience Receives FDA Fast Track Designation for Abenacianine for Injection (VGT-309) to Help Surgeons Visualize Tumors in the Lung During Surgery

January 8th, 2025|Medical Device News Magazine|

“Receiving Fast Track designation from the FDA reinforces the potential of abenacianine to address existing deficits in lung cancer surgery by helping surgeons better visualize tumors in the lung during minimally invasive surgical procedures,” said